Skip to content

Clinical trials

Phase 1/2 Central Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Phase 1/2 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20102
20112
20121
20131
20171
20192
20202
20211
20225
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Active, not recruiting3
Terminated3
Withdrawn3
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
4D Molecular Therapeutics2
AC Immune SA2
AskBio France, SAS, a subsidiary of AskBio Inc.1
BBB-Therapeutics B.V.1
Biogen1
Children's Hospital Medical Center, Cincinnati1
Eisai Inc.1
Forge Biologics, Inc1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases24
Brain Diseases13
Nervous System Diseases10
Brain Neoplasms6
Neurodegenerative Diseases5
Alzheimer Disease4
Breast Neoplasms4
Dementia4
Genetic Diseases, Inborn4
Metabolic Diseases4

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.